Zivo Bioscience (ZIVO) Screams 2,608% Higher AFTER Reverse Split!
Okay, that's it. We are officially enamored with post reverse split trading!
First, there was our client, LQR House (LQR), then Polished (POL) and...
Top 10 AI Titans.
Delve into the pinnacle of AI innovation. This report is your guide to the seismic shifts in AI startups, the rise of ethical AI,...
Research Report: Society Pass (SOPA) $0.22. Price Target $4.00.
Three New Reports on Society Pass (SOPA) With Price Targets from $3.00 to $4.00.
(All Report Archive)
December 27th, 2023. Litchfield Hills Research – $4.00 Price...
ATCC Announces $87 Million Award for Project NextGen for Vaccines, from Barda.
ATCC, the world’s premier biological materials management and standards organization, today announced a five-year, $87 million award from the Biomedical Advanced Research and Development...
Ardelyx (ARDX), Raymond James up Price Target, Citigroup Joins the Party.
Wall Street Cozy's up to Ardelyx After New Guidance.
On January 8th, Mike Raab, President and Chief Executive Officer stated, "We consistently grew sales of...
Is David Dodd on to his Next Billion Dollar Payday for Shareholders?
Huge News: Gedeptin® Therapy Demonstrated Safety, Stabilization and Shrinkage of Treated Tumors.
GeoVax (GOVX) Completes Patient Enrollment for Head & Neck Cancer Drug, Gedeptin.®
David...
Happy New Year! Year End Charts.
Expect 2024 to be Year of Both Massive of Gains (and Losses) Plus Massive Volatility. Be Prepared!
2023 YEAR END CHARTS
Dow Jones Industrial Average
S&P 500
NASDAQ...
Citius Pharmaceuticals, Inc. (CTXR) Reports Fiscal Full Year 2023 Financial Results and Provides Business...
Mino-Lok® Pivotal Phase 3 trial enrollment completed; topline data expected 2Q 2024
LYMPHIR™ BLA resubmission on track for early 2024
CRANFORD, N.J., Jan. 2, 2024 /PRNewswire/ -- Citius Pharmaceuticals,...
Pharmather (PHRRF) Has Officially Broken Out.
Read Corporate Presentation Today.
Pharmather (PHRRF) which we gave a 'heads-up,' because looked like it was about to break above resistance last week, has soundly...
Post Reverse Split Mania!
Now Wait a Minute, Aren't Stocks That do Reverse Splits Supposed go Down and Stay Down?
First our client LQR House (LQR) goes from $1.00...
Latest article
GeoVax (GOVX) Monkeypox (MPOX) PowerPoint.
In a recent press release, GeoVax shared progress on their MPOX Vaccine.
The planned Phase 3 immuno-bridging arm of the clinical trial is expected to...
Rick Rule Symposium – Conference Cheat Sheet
Natural Resource Investing Symposium - Presenter Guide
We've attended hundreds and hundreds of Investment Conferences (Barclay, JP Morgan, LD Micro, Piper Sandler, Roth, VRIC) since...
GeoVax (GOVX) Surges 256%, With 207 Million Shares Trading!
What an Entertaining Week!
..and it's only Thursday.
LIVE QUOTE
(MAY 18TH)
(MAY 21ST)
So Where Does That Leave us Today?
Yes, it was a pleasant surprise to see GeoVax...
